Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00095381
Status:
COMPLETED
Last Update Posted:
2012-01-19
First Post:
2004-11-03
Brief Title:
Repeat-Dose of Forodesine Hydrochloride BCX-1777 Infusion in Patients With Advanced T-Cell Leukemia
Sponsor:
BioCryst Pharmaceuticals
Organization:
BioCryst Pharmaceuticals
Organization Data
Organization:
BioCryst Pharmaceuticals
Class:
INDUSTRY
Study ID:
BCX1777-T-04-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioCryst Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None